{
    "root": "30a04a9e-783b-9d04-e063-6394a90ac631",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Metoprolol Succinate",
    "value": "20250318",
    "ingredients": [
        {
            "name": "ETHYLCELLULOSE (10 MPA.S)",
            "code": "3DYK7UYZ62",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11228"
        },
        {
            "name": "HYPROMELLOSE 2208 (4000 MPA.S)",
            "code": "39J80LT57T",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "HYPROMELLOSE 2910 (5 MPA.S)",
            "code": "R75537T0T4",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "LECITHIN, SOYBEAN",
            "code": "1DI56QDM62",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_61995"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "POLYETHYLENE GLYCOL 4000",
            "code": "4R4HFI6D95",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "METOPROLOL TARTRATE",
            "code": "W5S57Y3A5L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6906"
        }
    ],
    "indications": {
        "text": "metoprolol succinate extended-release tablets , metoprolol succinate , beta-adrenergic blocker indicated treatment : hypertension , lower blood pressure . lowering blood pressure reduces risk fatal non-fatal cardiovascular events , primarily strokes myocardial infarctions . ( 1.1 ) angina pectoris . ( 1.2 ) heart failure , reduce risk cardiovascular mortality heart failure hospitalizations patients heart failure ( 1.3 )",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "metoprolol succinate extended-release tablets extended-release tablets intended daily . treatment hypertension angina , switching immediate-release metoprolol metoprolol succinate extended-release tablets , total daily dose metoprolol succinate extended-release tablets . individualize metoprolol succinate extended-release tablets . titration may needed patients . metoprolol succinate extended-release tablets scored divided ; however , crush chew whole half tablet .",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "tablets containing metoprolol succinate equivalent indicated weight metoprolol tartrate , usp , white , biconvex , film-coated , scored . tablet shape engraving ndc # package 50 mg round e71 72789-497-90 bottle 90 store 25\u2103 ( 77\u00b0f ) ; excursions permitted 15\u2103-30\u2103 ( 59\u00b0f-86\u00b0f ) . ( usp controlled room temperature . ) protect moisture .",
    "adverseReactions": "metoprolol succinate extended-release tablets contraindicated severe bradycardia , second third degree heart block , cardiogenic shock , decompensated heart failure , sick sinus syndrome ( unless permanent pacemaker place ) , patients hypersensitive component product .",
    "indications_original": "Metoprolol succinate extended-release tablets, metoprolol succinate, beta-adrenergic blocker indicated for the treatment of: Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.( 1.1 ) Angina Pectoris. ( 1.2 ) Heart Failure, to reduce the risk of cardiovascular mortality and heart failure hospitalizations in patients with heart failure( 1.3 )",
    "contraindications_original": "Metoprolol succinate extended-release tablets are extended-release tablets intended for once daily administration. For treatment of hypertension and angina, when switching from immediate-release metoprolol to metoprolol succinate extended-release tablets, use the same total daily dose of metoprolol succinate extended-release tablets. Individualize the dosage of metoprolol succinate extended-release tablets. Titration may be needed in some patients.\n                  Metoprolol succinate extended-release tablets are scored and can be divided; however, do not crush or chew the whole or half tablet.",
    "warningsAndPrecautions_original": "Tablets containing metoprolol succinate equivalent to the indicated weight of metoprolol tartrate, USP, are white, biconvex, film-coated, and scored.\n                  \n                     \n                        \n                           Tablet\n                           Shape\n                           Engraving\n                           NDC#\n                           Package\n                        \n                     \n                     \n                        \n                           50 mg\n                           Round\n                           e71\n                           72789-497-90\n                           Bottle of 90\n                        \n                     \n                  \n                  Store at 25\u2103 (77\u00b0F); excursions permitted to 15\u2103-30\u2103 (59\u00b0F-86\u00b0F). (See USP Controlled Room Temperature.) Protect from moisture.",
    "adverseReactions_original": "Metoprolol succinate extended-release tablets are contraindicated in severe bradycardia, second or third degree heart block, cardiogenic shock, decompensated heart failure, sick sinus syndrome (unless a permanent pacemaker is in place), and in patients who are hypersensitive to any component of this product.",
    "drug": [
        {
            "name": "Metoprolol Succinate",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6905"
        }
    ]
}